tradingkey.logo

Fortrea Holdings Inc

FTRE
17.700USD
-0.210-1.17%
收盤 12/24, 13:00美東報價延遲15分鐘
1.63B總市值
虧損本益比TTM

Fortrea Holdings Inc

17.700
-0.210-1.17%

關於 Fortrea Holdings Inc 公司

Fortrea Holdings Inc. is a global contract research organization (CRO), which provides clinical development solutions to the life sciences industry. The Company is engaged in providing biopharmaceutical product and medical device development services to pharmaceutical, biotechnology and medical device customers. The Company offers customers flexible delivery models that include full service, functional service provider, and hybrid service structures. It provides phase I-IV clinical trial management, clinical pharmacology and consulting services. The Company manages its business through a single segment, Clinical Services, that provides services across the clinical pharmacology and clinical development spectrum. The Company has access to all key markets worldwide through a footprint of primary office locations in five countries (the United States, the United Kingdom, China, India and Singapore) with field operations in other jurisdictions worldwide.

Fortrea Holdings Inc簡介

公司代碼FTRE
公司名稱Fortrea Holdings Inc
上市日期Jun 16, 2023
CEOThakrala (Anshul)
員工數量15500
證券類型Ordinary Share
年結日Jun 16
公司地址8 Moore Drive
城市DURHAM
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編27709
電話18774950816
網址https://www.fortrea.com/
公司代碼FTRE
上市日期Jun 16, 2023
CEOThakrala (Anshul)

Fortrea Holdings Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Chairman of the Board
Chairman of the Board
98.13K
+175.40%
Dr. Amrit Ray, M.D.
Dr. Amrit Ray, M.D.
Lead Independent Director
Lead Independent Director
13.64K
+114.60%
Mr. Edward A. Pesicka
Mr. Edward A. Pesicka
Independent Director
Independent Director
13.64K
+114.60%
Mr. David Ross Smith
Mr. David Ross Smith
Independent Director
Independent Director
9.54K
+114.62%
Ms. Machelle Sanders
Ms. Machelle Sanders
Independent Director
Independent Director
7.28K
--
Ms. Jill Mcconnell
Ms. Jill Mcconnell
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Mark Morais
Mr. Mark Morais
Chief Operating Officer and President - Clinical Services
Chief Operating Officer and President - Clinical Services
--
--
Mr. William J. (Bill) Sharbaugh
Mr. William J. (Bill) Sharbaugh
Director
Director
--
--
Ms. Erin L. Russell
Ms. Erin L. Russell
Independent Director
Independent Director
--
--
Ms. Hima B. Inguva
Ms. Hima B. Inguva
Investor Relations
Investor Relations
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Chairman of the Board
Chairman of the Board
98.13K
+175.40%
Dr. Amrit Ray, M.D.
Dr. Amrit Ray, M.D.
Lead Independent Director
Lead Independent Director
13.64K
+114.60%
Mr. Edward A. Pesicka
Mr. Edward A. Pesicka
Independent Director
Independent Director
13.64K
+114.60%
Mr. David Ross Smith
Mr. David Ross Smith
Independent Director
Independent Director
9.54K
+114.62%
Ms. Machelle Sanders
Ms. Machelle Sanders
Independent Director
Independent Director
7.28K
--
Ms. Jill Mcconnell
Ms. Jill Mcconnell
Chief Financial Officer
Chief Financial Officer
--
--

收入明細

單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q3
FY2022Q2
FY2021
FY2020
由於公司未披露,未能獲取相關數據
地區USD
名稱
營收
佔比
North America
344.30M
48.47%
Europe
218.70M
30.79%
Other
147.30M
20.74%
業務
地區
由於公司未披露,未能獲取相關數據

股東統計

更新時間: 11月19日 週三
更新時間: 11月19日 週三
持股股東
股東類型
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
13.71%
The Vanguard Group, Inc.
8.69%
Goldman Sachs & Company, Inc.
8.54%
Corvex Management LP
4.88%
State Street Investment Management (US)
4.41%
其他
59.78%
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
13.71%
The Vanguard Group, Inc.
8.69%
Goldman Sachs & Company, Inc.
8.54%
Corvex Management LP
4.88%
State Street Investment Management (US)
4.41%
其他
59.78%
股東類型
持股股東
佔比
Investment Advisor
46.30%
Hedge Fund
22.80%
Investment Advisor/Hedge Fund
18.39%
Research Firm
13.93%
Pension Fund
1.41%
Bank and Trust
1.32%
Individual Investor
0.51%
Family Office
0.31%
Holding Company
0.05%

機構持股

更新時間: 12月8日 週一
更新時間: 12月8日 週一
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
861
101.77M
121.97%
--
2025Q3
941
101.78M
123.79%
-128.81K
2025Q2
971
101.91M
125.96%
+8.10M
2025Q1
934
96.29M
123.92%
-15.90M
2024Q4
888
96.88M
127.14%
-3.71M
2024Q3
843
100.39M
126.92%
-3.95M
2024Q2
819
103.77M
114.37%
+7.39M
2024Q1
774
92.63M
104.75%
-1.02M
2023Q4
713
91.56M
111.23%
-6.24M
2023Q3
611
90.56M
44.21%
+51.30M
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
BlackRock Institutional Trust Company, N.A.
12.74M
14.03%
+1.79M
+16.37%
Jun 30, 2025
The Vanguard Group, Inc.
8.51M
9.37%
-1.34M
-13.61%
Jun 30, 2025
Goldman Sachs & Company, Inc.
7.74M
8.53%
+7.70M
+19444.90%
Jun 30, 2025
Corvex Management LP
4.51M
4.97%
+33.63K
+0.75%
Jun 30, 2025
State Street Investment Management (US)
4.43M
4.88%
+1.17M
+35.82%
Jun 30, 2025
Sessa Capital
3.99M
4.4%
-700.00K
-14.91%
Jun 30, 2025
AQR Capital Management, LLC
6.52M
7.18%
+5.42M
+494.84%
Jun 30, 2025
Fidelity Management & Research Company LLC
2.98M
3.28%
-1.07M
-26.50%
Jun 30, 2025
Charles Schwab Investment Management, Inc.
1.79M
1.97%
+837.64K
+87.99%
Jun 30, 2025
DWS Investments UK Limited
1.63M
1.79%
+462.75K
+39.79%
Jun 30, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
Brandes US Small-Mid Cap Value ETF
1.39%
Invesco S&P Spin-Off ETF
0.97%
Invesco S&P SmallCap Health Care ETF
0.58%
Invesco S&P SmallCap 600 Revenue ETF
0.25%
Invesco S&P SmallCap 600 Pure Value ETF
0.23%
Schwab Fundamental U.S. Small Company ETF
0.17%
iShares S&P Small-Cap 600 Value ETF
0.16%
Humankind US Stock ETF
0.14%
ProShares Ultra Nasdaq Biotechnology
0.14%
State Street SPDR S&P 600 Small Cap Value ETF
0.13%
查看更多
Brandes US Small-Mid Cap Value ETF
佔比1.39%
Invesco S&P Spin-Off ETF
佔比0.97%
Invesco S&P SmallCap Health Care ETF
佔比0.58%
Invesco S&P SmallCap 600 Revenue ETF
佔比0.25%
Invesco S&P SmallCap 600 Pure Value ETF
佔比0.23%
Schwab Fundamental U.S. Small Company ETF
佔比0.17%
iShares S&P Small-Cap 600 Value ETF
佔比0.16%
Humankind US Stock ETF
佔比0.14%
ProShares Ultra Nasdaq Biotechnology
佔比0.14%
State Street SPDR S&P 600 Small Cap Value ETF
佔比0.13%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據

常見問題

Fortrea Holdings Inc的前五大股東是誰?

Fortrea Holdings Inc的前五大股東如下:
BlackRock Institutional Trust Company, N.A.
持有股份:12.74M
佔總股份比例:14.03%。
The Vanguard Group, Inc.
持有股份:8.51M
佔總股份比例:9.37%。
Goldman Sachs & Company, Inc.
持有股份:7.74M
佔總股份比例:8.53%。
Corvex Management LP
持有股份:4.51M
佔總股份比例:4.97%。
State Street Investment Management (US)
持有股份:4.43M
佔總股份比例:4.88%。

Fortrea Holdings Inc的前三大股東類型是什麼?

Fortrea Holdings Inc 的前三大股東類型分別是:
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Goldman Sachs & Company, Inc.

有多少機構持有Fortrea Holdings Inc(FTRE)的股份?

截至2025Q4,共有861家機構持有Fortrea Holdings Inc的股份,合計持有的股份價值約為101.77M,占公司總股份的121.97% 。與2025Q3相比,機構持股有所增加,增幅為-1.82%。

哪個業務部門對Fortrea Holdings Inc的收入貢獻最大?

在FY2025Q2,--業務部門對Fortrea Holdings Inc的收入貢獻最大,創收--,占總收入的--% 。
KeyAI